Immatics (NASDAQ:IMTXW) Short Interest Update

Immatics (NASDAQ:IMTXW) was the recipient of a significant increase in short interest during the month of November. As of November 15th, there was short interest totalling 900 shares, an increase of 28.6% from the October 31st total of 700 shares. Based on an average daily trading volume, of 17,800 shares, the days-to-cover ratio is presently 0.1 days.

Immatics Trading Down 20.2 %

Shares of NASDAQ IMTXW traded down $0.10 during mid-day trading on Monday, reaching $0.40. The company had a trading volume of 959,351 shares, compared to its average volume of 16,574. Immatics has a twelve month low of $0.35 and a twelve month high of $4.14. The stock’s 50 day moving average is $1.23 and its 200-day moving average is $2.29.

Immatics Company Profile

Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the research and development of potential T cell redirecting immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as TCR-engineered autologous or allogeneic adoptive cell therapies (ACT) and antibody-like TCR Bispecifics.